Thomas E. Clancy - Concepedia

Author

Thomas E. Clancy

Also Known As

Carlo Ceresa, Sameer Hirji, T. Clancy, T. E. Clancy, T.E. Clancy, THOMAS E. CLANCY, Thomas Clancy, Thomas E Clancy, Thomas E. Clancy, Thomas Russell

399

Publications

10K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Dana-Farber Cancer Institute Dana-Farber Brigham Cancer Center Broad Institute

About

Thomas E. Clancy is an author at Brigham and Women's Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	4K
2	Public Health	5	5	109
3	Health Sciences	4	4	114
4	Cell Biology	2	2	55
5	Education	1	1	21

Thomas E. Clancy

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment Aleksandar D. Kostic, Eunyoung Chun, Lauren Robertson, Cell Host & Microbe DysbiosisMucosal ImmunologyImmunologyPathologyTumor-immune Microenvironment	2013	2.6K
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska, Science	2017	1.4K
Spatially organized multicellular immune hubs in human colorectal cancer Karin Pelka, Matan Hofree, Jonathan Chen, Cell	2021	727
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer Srivatsan Raghavan, Peter Winter, Andrew W. Navia, Cell	2021	537
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer Jens G. Lohr, Viktor A. Adalsteinsson, Kristian Cibulskis, Nature Biotechnology	2014	531
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda, Cancer Discovery	2018	359
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma Zhi Rong Qian, Douglas A. Rubinson, Jonathan A. Nowak, JAMA Oncology	2017	264
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer Matthew B. Yurgelun, Anu Chittenden, Vicente Morales‐Oyarvide, Genetics in Medicine Survival OutcomesPancreatic CancerSomatic VariantMedicineGenetics	2018	212
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection Johannes F. Fahrmann, C. Max Schmidt, Xiangying Mao, Gastroenterology OncologyPancreatic CancerCancer DetectionMedicinePathology	2020	184
Adenocarcinoma of the gastric cardia: What is the optimal surgical approach? Hiromichi Ito, Thomas E. Clancy, Robert T. Osteen, Journal of the American College of Surgeons	2004	154

Page 1